View in EDS HTML Full Text PDF Full Text

Preferential expression of SCN1A in GABAergic neurons improves survival and epileptic phenotype in a mouse model of Dravet syndrome.

Saved in:
Bibliographic Details
Title: Preferential expression of SCN1A in GABAergic neurons improves survival and epileptic phenotype in a mouse model of Dravet syndrome.
Authors: Ricobaraza A; Gene Therapy and Regulation of Gene Expression Program, CIMA, University of Navarra, CIMA, Av. Pio XII 55, E-31008, Pamplona, Spain., Bunuales M; Gene Therapy and Regulation of Gene Expression Program, CIMA, University of Navarra, CIMA, Av. Pio XII 55, E-31008, Pamplona, Spain., Gonzalez-Aparicio M; Gene Therapy and Regulation of Gene Expression Program, CIMA, University of Navarra, CIMA, Av. Pio XII 55, E-31008, Pamplona, Spain., Fadila S; Sackler Faculty of Medicine, Goldschleger Eye Research Institute, Tel Aviv University, Tel Aviv, Israel.; Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Rubinstein M; Sackler Faculty of Medicine, Goldschleger Eye Research Institute, Tel Aviv University, Tel Aviv, Israel.; Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel., Vides-Urrestarazu I; Gene Therapy and Regulation of Gene Expression Program, CIMA, University of Navarra, CIMA, Av. Pio XII 55, E-31008, Pamplona, Spain., Banderas J; Gene Therapy and Regulation of Gene Expression Program, CIMA, University of Navarra, CIMA, Av. Pio XII 55, E-31008, Pamplona, Spain., Sola-Sevilla N; Gene Therapy and Regulation of Gene Expression Program, CIMA, University of Navarra, CIMA, Av. Pio XII 55, E-31008, Pamplona, Spain., Sanchez-Carpintero R; University Clinic of Navarra, Dravet Syndrome Unit, Pediatric Neurology Unit, IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Lanciego JL; Department of Neuroscience, CIMA, University of Navarra, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CiberNed), Madrid, Spain., Roda E; Department of Neuroscience, CIMA, University of Navarra, Pamplona, Spain., Honrubia A; Department of Neuroscience, CIMA, University of Navarra, Pamplona, Spain., Arnaiz P; Department of Neuroscience, CIMA, University of Navarra, Pamplona, Spain., Hernandez-Alcoceba R; Gene Therapy and Regulation of Gene Expression Program, CIMA, University of Navarra, CIMA, Av. Pio XII 55, E-31008, Pamplona, Spain. rubenh@unav.es.
Source: Journal of molecular medicine (Berlin, Germany) [J Mol Med (Berl)] 2023 Dec; Vol. 101 (12), pp. 1587-1601. Date of Electronic Publication: 2023 Oct 11.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 9504370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1440 (Electronic) Linking ISSN: 09462716 NLM ISO Abbreviation: J Mol Med (Berl) Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37819378
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Preferential expression of SCN1A in GABAergic neurons improves survival and epileptic phenotype in a mouse model of Dravet syndrome.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ricobaraza+A%22">Ricobaraza A</searchLink>; Gene Therapy and Regulation of Gene Expression Program, CIMA, University of Navarra, CIMA, Av. Pio XII 55, E-31008, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Bunuales+M%22">Bunuales M</searchLink>; Gene Therapy and Regulation of Gene Expression Program, CIMA, University of Navarra, CIMA, Av. Pio XII 55, E-31008, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Gonzalez-Aparicio+M%22">Gonzalez-Aparicio M</searchLink>; Gene Therapy and Regulation of Gene Expression Program, CIMA, University of Navarra, CIMA, Av. Pio XII 55, E-31008, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Fadila+S%22">Fadila S</searchLink>; Sackler Faculty of Medicine, Goldschleger Eye Research Institute, Tel Aviv University, Tel Aviv, Israel.; Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Rubinstein+M%22">Rubinstein M</searchLink>; Sackler Faculty of Medicine, Goldschleger Eye Research Institute, Tel Aviv University, Tel Aviv, Israel.; Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Vides-Urrestarazu+I%22">Vides-Urrestarazu I</searchLink>; Gene Therapy and Regulation of Gene Expression Program, CIMA, University of Navarra, CIMA, Av. Pio XII 55, E-31008, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Banderas+J%22">Banderas J</searchLink>; Gene Therapy and Regulation of Gene Expression Program, CIMA, University of Navarra, CIMA, Av. Pio XII 55, E-31008, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Sola-Sevilla+N%22">Sola-Sevilla N</searchLink>; Gene Therapy and Regulation of Gene Expression Program, CIMA, University of Navarra, CIMA, Av. Pio XII 55, E-31008, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Sanchez-Carpintero+R%22">Sanchez-Carpintero R</searchLink>; University Clinic of Navarra, Dravet Syndrome Unit, Pediatric Neurology Unit, IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Lanciego+JL%22">Lanciego JL</searchLink>; Department of Neuroscience, CIMA, University of Navarra, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CiberNed), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Roda+E%22">Roda E</searchLink>; Department of Neuroscience, CIMA, University of Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Honrubia+A%22">Honrubia A</searchLink>; Department of Neuroscience, CIMA, University of Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Arnaiz+P%22">Arnaiz P</searchLink>; Department of Neuroscience, CIMA, University of Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Hernandez-Alcoceba+R%22">Hernandez-Alcoceba R</searchLink>; Gene Therapy and Regulation of Gene Expression Program, CIMA, University of Navarra, CIMA, Av. Pio XII 55, E-31008, Pamplona, Spain. rubenh@unav.es.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229504370%22">Journal of molecular medicine (Berlin, Germany)</searchLink> [J Mol Med (Berl)] 2023 Dec; Vol. 101 (12), pp. 1587-1601. <i>Date of Electronic Publication: </i>2023 Oct 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+International%22">Springer International </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>9504370 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-1440 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209462716%22">09462716 </searchLink><i>NLM ISO Abbreviation: </i>J Mol Med (Berl) <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37819378
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00109-023-02383-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1587
    Titles:
      – TitleFull: Preferential expression of SCN1A in GABAergic neurons improves survival and epileptic phenotype in a mouse model of Dravet syndrome.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ricobaraza A
      – PersonEntity:
          Name:
            NameFull: Bunuales M
      – PersonEntity:
          Name:
            NameFull: Gonzalez-Aparicio M
      – PersonEntity:
          Name:
            NameFull: Fadila S
      – PersonEntity:
          Name:
            NameFull: Rubinstein M
      – PersonEntity:
          Name:
            NameFull: Vides-Urrestarazu I
      – PersonEntity:
          Name:
            NameFull: Banderas J
      – PersonEntity:
          Name:
            NameFull: Sola-Sevilla N
      – PersonEntity:
          Name:
            NameFull: Sanchez-Carpintero R
      – PersonEntity:
          Name:
            NameFull: Lanciego JL
      – PersonEntity:
          Name:
            NameFull: Roda E
      – PersonEntity:
          Name:
            NameFull: Honrubia A
      – PersonEntity:
          Name:
            NameFull: Arnaiz P
      – PersonEntity:
          Name:
            NameFull: Hernandez-Alcoceba R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2023 Dec
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1432-1440
          Numbering:
            – Type: volume
              Value: 101
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Journal of molecular medicine (Berlin, Germany)
              Type: main
ResultId 1